The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis

The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis

Show other versions (1)

Objective: To estimate the pooled prevalence of cancer in patients with multiple sclerosis (MS) cases who were under treatment with rituximab. Methods: We searched PubMed, Scopus, EMBASE, Web of Science, and google scholar along with gray literature up to April 2021.The search strategy included the...

Full description

Saved in:
Bibliographic Details
Main Authors: O. Mirmosayyeb, V. Shaygannejad, N. Ebrahimi, H. Ghoshouni, M. Ghajarzadeh
Format: Article
Language:Spanish
Published: Elsevier España 2025-01-01
Series:Neurología
Subjects:
Neoplasia
Esclerosis múltiple
Revisión sistemática
Online Access:http://www.sciencedirect.com/science/article/pii/S0213485322000949
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items